Sunday - February 1, 2026
New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause
January 22, 2026
ROCHESTER, Minnesota, Jan. 22 [Category: BizHospital] -- The Mayo Clinic issued the following news release:

* * *

New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause

*

JACKSONVILLE, Fla. -A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products